Citation Formats
Triple test with tumor markers CYFRA 21.1, HE4, and ProGRP might contribute to diagnosis and subtyping of lung cancer
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

E. T. Korkmaz Et Al. , "Triple test with tumor markers CYFRA 21.1, HE4, and ProGRP might contribute to diagnosis and subtyping of lung cancer," CLINICAL BIOCHEMISTRY , vol.58, pp.15-19, 2018

Korkmaz, E. T. Et Al. 2018. Triple test with tumor markers CYFRA 21.1, HE4, and ProGRP might contribute to diagnosis and subtyping of lung cancer. CLINICAL BIOCHEMISTRY , vol.58 , 15-19.

Korkmaz, E. T., KÖKSAL, D., Aksu, F., DİKMEN, Z. G., İÇEN, D., Maden, E., ... Onder, S.(2018). Triple test with tumor markers CYFRA 21.1, HE4, and ProGRP might contribute to diagnosis and subtyping of lung cancer. CLINICAL BIOCHEMISTRY , vol.58, 15-19.

Korkmaz, Elif Et Al. "Triple test with tumor markers CYFRA 21.1, HE4, and ProGRP might contribute to diagnosis and subtyping of lung cancer," CLINICAL BIOCHEMISTRY , vol.58, 15-19, 2018

Korkmaz, Elif T. Et Al. "Triple test with tumor markers CYFRA 21.1, HE4, and ProGRP might contribute to diagnosis and subtyping of lung cancer." CLINICAL BIOCHEMISTRY , vol.58, pp.15-19, 2018

Korkmaz, E. T. Et Al. (2018) . "Triple test with tumor markers CYFRA 21.1, HE4, and ProGRP might contribute to diagnosis and subtyping of lung cancer." CLINICAL BIOCHEMISTRY , vol.58, pp.15-19.

@article{article, author={Elif Tugce Korkmaz Et Al. }, title={Triple test with tumor markers CYFRA 21.1, HE4, and ProGRP might contribute to diagnosis and subtyping of lung cancer}, journal={CLINICAL BIOCHEMISTRY}, year=2018, pages={15-19} }